BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7970850)

  • 1. Use of Memokath, a second generation urethral stent for relief of urinary retention in male spinal cord injured patients.
    Soni BM; Vaidyanatham S; Krishnan KR
    Paraplegia; 1994 Jul; 32(7):480-8. PubMed ID: 7970850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term result of Memokath urethral sphincter stent in spinal cord injury patients.
    Vaidyanathan S; Soni BM; Oo T; Sett P; Hughes PL; Singh G
    BMC Urol; 2002 Nov; 2():12. PubMed ID: 12427256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a removable stent in patients with prostate cancer and obstruction.
    Yachia D; Aridogan IA
    J Urol; 1996 Jun; 155(6):1956-8. PubMed ID: 8618296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memokath stents for the treatment of detrusor sphincter dyssynergia (DSD) in men with spinal cord injury: the Princess Royal Spinal Injuries Unit 10-year experience.
    Mehta SS; Tophill PR
    Spinal Cord; 2006 Jan; 44(1):1-6. PubMed ID: 16044169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Memokath temporary urethral stent in treatment of detrusor-sphincter dyssynergia.
    Shah NC; Foley SJ; Edhem I; Shah PJ
    J Endourol; 1997 Dec; 11(6):485-8. PubMed ID: 9440862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memokath: a second generation of intraprostatic spirals.
    Poulsen AL; Schou J; Ovesen H; Nordling J
    Br J Urol; 1993 Sep; 72(3):331-4. PubMed ID: 7693295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the Memokath stent in the treatment of detrusor sphincter dyssynergia in spinal cord injury patients: a single-centre seven-year experience.
    Hamid R; Arya M; Wood S; Patel HR; Shah PJ
    Eur Urol; 2003 May; 43(5):539-43. PubMed ID: 12706000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible clinical outcome after sphincter stent removal.
    Chancellor MB; Rivas DA; Watanabe T; Bennett JK; Foote JE; Green BG; Killorin EW; MacMillan R
    J Urol; 1996 Jun; 155(6):1992-4. PubMed ID: 8618306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UroLume stents: lessons learned.
    Wilson TS; Lemack GE; Dmochowski RR
    J Urol; 2002 Jun; 167(6):2477-80. PubMed ID: 11992061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral placement of external sphincter wire mesh stent for neurogenic bladder.
    Abdill CK; Rivas DR; Chancellor MB
    SCI Nurs; 1994 Jun; 11(2):38-41. PubMed ID: 7863317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results and indications of intraurethral stents in elderly patients with prostatic hypertrophy complaining of urinary retention].
    Takeda M; Takahashi H; Tsutsui T; Go H; Hatano A; Sato S; Sasagawa T; Sakata Y; Hiraiwa M; Ando T
    Hinyokika Kiyo; 1993 Nov; 39(11):1011-5. PubMed ID: 7505521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A urethral stent for the treatment of detrusor-striated sphincter dyssynergia.
    Chartier-Kastler EJ; Thomas L; Bussel B; Chancellor MB; Richard F; Denys P
    BJU Int; 2000 Jul; 86(1):52-7. PubMed ID: 10886083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary catheterization: transurethral or suprapubic approach?].
    Piergiovanni M; Tschantz P
    Helv Chir Acta; 1991 Jul; 58(1-2):201-5. PubMed ID: 1938446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
    Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
    BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with Memokath 051 ureteral stent.
    Klarskov P; Nordling J; Nielsen JB
    Scand J Urol Nephrol; 2005; 39(2):169-72. PubMed ID: 16019773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesh-like tubular stent treatment for chronic urinary retention caused by benign prostatic hypertrophy].
    Wang X; Zhu J; Hou S
    Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):107-9. PubMed ID: 9388336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UroLume endoprosthesis: a summary of the European and North American experience.
    Oesterling JE
    Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to manage acute urethral false passage due to intermittent catheterization in spinal cord injured patients who refused insertion of an indwelling catheter.
    Gökalp A; Yildirim I; Aydur E; Göktepe S; Başal S; Yazicioğlu K
    J Urol; 2003 Jan; 169(1):203-6. PubMed ID: 12478136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new thermo-expandable shape-memory nickel-titanium alloy stent for the management of ureteric strictures.
    Kulkarni RP; Bellamy EA
    BJU Int; 1999 May; 83(7):755-9. PubMed ID: 10368191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the management of urethral stones presenting with urinary retention at Gusau.
    Ahmed A; Saeed NM
    Niger J Clin Pract; 2008 Dec; 11(4):309-11. PubMed ID: 19320400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.